Insights & News / Investments

June 3, 2019

Barnea Represents Johnson & Johnson Innovation in Investment Round in Techsomed

Adv. Micky Barnea, Adv. Ariella Dreyfuss, Adv. Itay Gura, and Adv. Mayer Winkler represented Johnson Johnson Innovation (JJDC) in an investment round in the Israeli medtech startup Techsomed Medical Technologies Ltd. Founded in 2012, Techsomed has developed an image analysis system that helps track tissue response to thermal ablation, the process of destroying tumors using extreme heat or cold. Techsomed intends to use the funding toward receiving regulatory approval in the US, Europe, and Japan. JJDC led the company's current round of financing, which included both former and new investors, such as Screen Holdings, the Alfred Mann Institute at the Technion (AMIT), NextLeap Ventures, and Axil Capital.

See full article >

May 15, 2019

Barnea Represents VVNP in Investment Round in Aleph Farms

Our firm represented the Singapore-based venture capital fund VisVires New Protein (VVNP) in an investment round in Aleph Farms, an Israeli food-tech startup.

See full article >

March 20, 2019

Barnea Represents Danel in Acquisition of Levinger Group

Our firm represented Danel Ltd. in a deal to acquire 51% of Levinger Group. This marks a strategic move by Danel to expand into the private health field.

See full article >

November 20, 2018

Barnea Represents Senetas Corporation in Investment in Votiro

Our firm represented Senetas Corporation in a USD 8 million investment in the Israeli cyber company Votiro Cybersec Global Limited.

See full article >

July 30, 2018

Barnea Represents JJDC as Lead Investor in OrthoSpin Ltd.

We represented the US pharmaceutical and medical devices company Johnson Johnson Development Corporation (JJDC) in a USD 3 million investment round in OrthoSpin Ltd,, an Israel-based startup that provides smart robotic external fixation systems.

See full article >

June 11, 2018

Barnea Represents Investor in Israeli Cybersecurity Company

Barnea advised an investor on a USD 60 million investment in Claroty, an Israeli company that specializes in cybersecurity for industrial control networks.

See full article >

February 1, 2018

Barnea Advises on CVC's USD 703 Million Acquisition of Theramex

Barnea advised on CVC Capital Partners' USD 703 million acquisition of Theramex, Teva Pharmaceutical Industries' global women’s health portfolio.

See full article >

May 9, 2018

Barnea Represents ADM Capital in Investment in Rootility

Barnea represented ADM Capital, a UK-based investment fund, in an investment round in the Israeli plant-breeding startup Rootility.

See full article >

March 27, 2018

Barnea Represents Cellebrite in Sale of Mobilogy Division to US Fund

Our firm represented Cellebrite in the sale of the Mobilogy Division to the US ESW Capital Fund. The Mobilogy division, which operates as a separate brand, offers technological solutions for operators, retailers, and aftermarket that enhance the customer experience in-store and beyond.

See full article >

April 10, 2018

IFLR 2018 M&A Israel Report

A report on the MA market in Israel was written by Adv. Ariella Dreyfuss and published on the international IFLR 1000 ranking guide's website. The report analyzes the trends and developments in the MA market in Israel.

See full article >

December 11, 2017

Barnea Represents EXO Technologies in Acquisition by Lear

We represented Israeli startup EXO Technologies, a developer of GPS technology for autonomous and connected vehicle applications, in its acquisition by the US corporation Lear.

See full article >

Previous 1 2 3 4

Together is empowering

Search by Practice

Insights & News / Investments